Back to search

Article

Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

2022-12-01

Abstract excerpt

<h4>Background: </h4> Triple antithrombotic therapy (TAT), a combination of an oral anticoagulant and dual antiplatelet agents (DAPT), is a key treatment for prevention of ischemic events in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). However, TAT is not extensively used because of the risk of bleeding. This study aimed to determine the utilization and influencing fa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2ed52eb-a26f-51ff-a1da-46bac36ad62a
DOI
10.21203/rs.3.rs-2323039/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDOI 10.21203/rs.3.rs-2323039/v1
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity
Contemporary burden of atrial fibrillation in mechanical thrombectomy stroke patients in the United StatesSemantic proximity
Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES TrialSemantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity
Long-Term Outcomes After Ischemic Stroke Across Atrial Fibrillation Phenotypes Defined by Detection Timing and Prior Anticoagulation Status.Semantic proximity
North American Thrombosis Forum, AF Action Initiative Consensus Document.Semantic proximity
Dual antiplatelet therapy in patients with coronary artery disease after percutaneous coronary intervention with drug-eluting stents: A systematic review and network meta-analysisSemantic proximity
Temporal Trends in Stroke Management and Outcomes between 2011 and 2020: Results from a Nationwide Multicenter RegistrySemantic proximity
Antithrombotic Therapy in Patients Undergoing Transcatheter Aortic Valve ImplantationSemantic proximity
Development and validation of a new nomogram model for predicting acute ischemic stroke in elderly patients with non-valvular atrial fibrillation:A single-center cross-sectional studySemantic proximity
Select a neighboring publication to make it the new centre.